Skip to main content
Clinical Trials/NCT03842423
NCT03842423
Completed
Not Applicable

Brachial Plexus Block in Children and Adolescents Requiring Surgery Following Trauma

Medical University of Vienna1 site in 1 country2,760 target enrollmentStarted: January 1, 2002Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
2,760
Locations
1
Primary Endpoint
Conversion to general anaesthesia

Overview

Brief Summary

This study involves a retrospective evaluation of brachial plexus anaesthesia in children and adolescents (patients under the age of 18) undergoing surgical procedures of the upper extremity following trauma. The investigators plan to recruit patients from our hospital patient database meeting our inclusion criteria. Observational period was defined between 1st of January 2002 and 31st of October 2018. Necessity to convert to general anaesthesia was defined as primary endpoint.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Brachial plexus anaesthesia for surgical intervention of upper extremity injuries

Exclusion Criteria

  • age above 18

Outcomes

Primary Outcomes

Conversion to general anaesthesia

Time Frame: intraoperatively

The necessity to convert to general anaesthesia will be obtained from surgery and anaesthesiology protocols and serves as primary outcome to evaluate efficacy of the investigated method of anaesthesia. All patients who received plexus brachialis anaesthesia but had to be converted to general anaesthesia during or prior the surgical intervention will assigned to this outcome measurement. Number of patients who required conversion will be given as percentage of total patient collective. Possible variables: e.g. 0=no conversion, 1=conversion.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Thomas Haider

Principal Investigator

Medical University of Vienna

Study Sites (1)

Loading locations...

Similar Trials